A detailed history of Fred Alger Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 4,012,000 shares of NTRA stock, worth $586 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares
4,012,000
Previous 5,262,664 23.76%
Holding current value
$586 Million
Previous $570 Million 10.52%
% of portfolio
2.57%
Previous 2.83%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $122 Million - $162 Million
-1,250,664 Reduced 23.76%
4,012,000 $510 Million
Q2 2024

Aug 14, 2024

SELL
$85.28 - $112.6 $110 Million - $145 Million
-1,284,263 Reduced 19.62%
5,262,664 $570 Million
Q1 2024

May 15, 2024

SELL
$59.21 - $92.9 $31.4 Million - $49.2 Million
-529,724 Reduced 7.49%
6,546,927 $599 Million
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $4.52 Million - $7.55 Million
120,465 Added 1.73%
7,076,651 $443 Million
Q3 2023

Nov 14, 2023

SELL
$43.4 - $62.52 $16 Million - $23.1 Million
-369,554 Reduced 5.04%
6,956,186 $308 Million
Q2 2023

Aug 14, 2023

SELL
$47.08 - $55.16 $23.2 Million - $27.2 Million
-493,185 Reduced 6.31%
7,325,740 $356 Million
Q1 2023

May 15, 2023

SELL
$36.57 - $58.29 $42.2 Million - $67.3 Million
-1,153,898 Reduced 12.86%
7,818,925 $434 Million
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $6.54 Million - $9.17 Million
191,477 Added 2.18%
8,972,823 $360 Million
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $56.7 Million - $86.9 Million
1,534,001 Added 21.17%
8,781,346 $385 Million
Q2 2022

Aug 15, 2022

BUY
$28.13 - $44.54 $22.5 Million - $35.7 Million
801,440 Added 12.43%
7,247,345 $257 Million
Q1 2022

May 16, 2022

SELL
$30.32 - $91.33 $10.9 Million - $32.8 Million
-359,123 Reduced 5.28%
6,445,905 $262 Million
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $11.5 Million - $15.9 Million
-133,827 Reduced 1.93%
6,805,028 $636 Million
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $67.6 Million - $85.3 Million
675,257 Added 10.78%
6,938,855 $773 Million
Q2 2021

Aug 16, 2021

BUY
$86.05 - $119.72 $41.8 Million - $58.1 Million
485,538 Added 8.4%
6,263,598 $711 Million
Q1 2021

May 17, 2021

SELL
$91.47 - $124.36 $40.2 Million - $54.7 Million
-439,620 Reduced 7.07%
5,778,060 $587 Million
Q4 2020

Feb 16, 2021

BUY
$66.66 - $111.74 $44 Million - $73.7 Million
659,389 Added 11.86%
6,217,680 $619 Million
Q3 2020

Nov 13, 2020

BUY
$45.89 - $72.67 $89.6 Million - $142 Million
1,952,490 Added 54.15%
5,558,291 $402 Million
Q2 2020

Aug 14, 2020

BUY
$26.36 - $49.86 $8.05 Million - $15.2 Million
305,243 Added 9.25%
3,605,801 $180 Million
Q1 2020

May 15, 2020

SELL
$17.27 - $40.17 $7.09 Million - $16.5 Million
-410,440 Reduced 11.06%
3,300,558 $98.6 Million
Q4 2019

Feb 14, 2020

SELL
$32.1 - $40.4 $609,097 - $766,590
-18,975 Reduced 0.51%
3,710,998 $125 Million
Q3 2019

Nov 14, 2019

BUY
$25.38 - $34.89 $2.35 Million - $3.23 Million
92,654 Added 2.55%
3,729,973 $122 Million
Q2 2019

Aug 14, 2019

SELL
$17.75 - $27.58 $10.6 Million - $16.4 Million
-595,181 Reduced 14.06%
3,637,319 $100 Million
Q1 2019

May 14, 2019

BUY
$11.34 - $20.62 $15 Million - $27.2 Million
1,320,188 Added 45.33%
4,232,500 $87.3 Million
Q4 2018

Feb 14, 2019

BUY
$12.32 - $24.38 $7.83 Million - $15.5 Million
635,462 Added 27.91%
2,912,312 $40.7 Million
Q3 2018

Nov 14, 2018

BUY
$18.82 - $28.96 $9.58 Million - $14.7 Million
509,017 Added 28.79%
2,276,850 $54.5 Million
Q2 2018

Jul 19, 2018

BUY
$8.79 - $19.98 $15.5 Million - $35.3 Million
1,767,833 New
1,767,833 $33.3 Million
Q4 2017

Feb 14, 2018

SELL
$8.99 - $14.31 $152,830 - $243,270
-17,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$8.02 - $13.33 $136,340 - $226,610
17,000
17,000 $219,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.